The company is tackling some of the major difficulties resulting in inequitable prognosis and therapy now with fast formulated AI items in upper body x-rays, brain CTs, all Along with the goal of encouraging clinicians make the best diagnoses faster and handle patients quicker.It is currently valued at roughly 470 billion won, with 46 billion gaine